• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

118例患者使用CryoLife-O'Brien复合无支架猪主动脉异种移植瓣膜。

The CryoLife-O'Brien composite stentless porcine aortic xenograft valve in 118 patients.

作者信息

Garlick R B, O'Brien M F

机构信息

Department of Cardiac Surgery, Prince Charles Hospital, Brisbane, Australia.

出版信息

Jpn Circ J. 1997 Aug;61(8):682-6. doi: 10.1253/jcj.61.682.

DOI:10.1253/jcj.61.682
PMID:9276773
Abstract

The CryoLife-O'Brien stentless valve is a composite trileaflet porcine aortic valve. It is assembled from 3 non-coronary leaflets and has no foreign material support. It is therefore truly stentless. From December 1992 to January 1996, 118 patients with aortic valve replacement had a CryoLife-O'Brien stentless valve inserted at the Prince Charles Hospital, Brisbane. The mean age was 73 years (range 59-89) and 54% were men. Most patients had aortic stenosis secondary to a calcific degenerative valve. Follow-up is 100% with hematological and echocardiographic studies before discharge, at 6 months, and at 12-18 months. Five deaths (2 early and 3 late) have occurred and morbidity includes 3 strokes, 1 peripheral embolism, 3 perivalvular leaks, and 1 patient with late endocarditis. Valve performance has been good, with low transvalvular gradients and only a trace or no regurgitation in over 95% of patients after 18 months. No structural deterioration or hemolysis has occurred. Echocardiographic surveillance confirms a very effective central orifice. Short-term results show that the overall performance of the CryoLife-O'Brien stentless valve has been very satisfactory, with low mortality and morbidity in this elderly group of patients. The benefits include the absence of prosthetic material, wide leaflet coaptation, and a quick and easy insertion. Long-term anticoagulation is not necessary. It is particularly suitable for elderly patients with a symmetrical aortic root.

摘要

CryoLife - O'Brien无支架瓣膜是一种复合三叶猪主动脉瓣。它由3个无冠状动脉瓣叶组装而成,没有异物支撑。因此它是真正的无支架瓣膜。1992年12月至1996年1月,118例接受主动脉瓣置换术的患者在布里斯班查尔斯王子医院植入了CryoLife - O'Brien无支架瓣膜。平均年龄为73岁(范围59 - 89岁),男性占54%。大多数患者患有继发于钙化性退行性瓣膜的主动脉瓣狭窄。出院前、6个月以及12 - 18个月时进行血液学和超声心动图研究,随访率达100%。已发生5例死亡(2例早期和3例晚期),发病情况包括3次中风、1次外周栓塞、3次瓣周漏以及1例晚期心内膜炎患者。瓣膜功能良好,跨瓣压差低,18个月后超过95%的患者仅有微量反流或无反流。未发生结构恶化或溶血。超声心动图监测证实中心孔非常有效。短期结果表明,CryoLife - O'Brien无支架瓣膜的总体性能非常令人满意,在这组老年患者中死亡率和发病率较低。其优点包括无人工材料、瓣叶贴合广泛、插入快速简便。无需长期抗凝。它特别适合主动脉根部对称的老年患者。

相似文献

1
The CryoLife-O'Brien composite stentless porcine aortic xenograft valve in 118 patients.118例患者使用CryoLife-O'Brien复合无支架猪主动脉异种移植瓣膜。
Jpn Circ J. 1997 Aug;61(8):682-6. doi: 10.1253/jcj.61.682.
2
The Cryolife-O'Brien stentless aortic porcine xenograft valve.Cryolife-O'Brien无支架猪主动脉异种移植瓣膜。
J Card Surg. 1998 Sep-Oct;13(5):376-85. doi: 10.1111/j.1540-8191.1998.tb01100.x.
3
Eight-year results after aortic valve replacement with the CryoLife-O'Brien Stentless Aortic Porcine Bioprosthesis.使用CryoLife-O'Brien无支架猪主动脉生物瓣膜进行主动脉瓣置换术后八年的结果。
J Thorac Cardiovasc Surg. 2005 Sep;130(3):777-82. doi: 10.1016/j.jtcvs.2005.05.011.
4
Aortic valve replacement with the Cryolife-O'Brien stentless aortic bioprosthesis: five-year experience.使用Cryolife-O'Brien无支架主动脉生物瓣膜进行主动脉瓣置换术:五年经验
J Cardiovasc Surg (Torino). 2004 Dec;45(6):557-63.
5
[Aortic valve replacement with a Cryolife O'Brien stentless bioprosthesis].[使用Cryolife O'Brien无支架生物瓣膜进行主动脉瓣置换术]
Rev Esp Cardiol. 2007 Jan;60(1):45-50.
6
Reoperation on stentless aortic xenografts.无支架主动脉异种移植物的再次手术
Ann Thorac Surg. 1998 Dec;66(6 Suppl):S104-9. doi: 10.1016/s0003-4975(98)01120-5.
7
Midterm results after aortic valve replacement with a stentless bioprosthesis aortic valve.无支架生物人工主动脉瓣置换术后的中期结果。
Ann Thorac Surg. 2005 Jul;80(1):198-203. doi: 10.1016/j.athoracsur.2005.01.027.
8
The stentless Cryolife-O'Brien aortic porcine xenograft: a five-year follow-up.
Ann Thorac Surg. 1998 Dec;66(6 Suppl):S134-8. doi: 10.1016/s0003-4975(98)01104-7.
9
The Cryolife-O'Brien composite aortic stentless xenograft: surgical technique of implantation.
Ann Thorac Surg. 1995 Aug;60(2 Suppl):S410-3. doi: 10.1016/0003-4975(95)00267-o.
10
Composite stentless xenograft for aortic valve replacement: clinical evaluation of function.
Ann Thorac Surg. 1995 Aug;60(2 Suppl):S406-9. doi: 10.1016/0003-4975(95)00224-9.

引用本文的文献

1
Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering.设计并表征一种可注射的心包膜基质胶:一种潜在的用于心脏组织工程的自体支架。
Tissue Eng Part A. 2010 Jun;16(6):2017-27. doi: 10.1089/ten.TEA.2009.0768.